Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

survivin

"Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer" (2018) Cerda-Opazo, P.;Valenzuela-Valderrama, M.;Wichmann, I. (...)Quest, A.F.G. Oncotarget. 9(16):12853-12867

"The RNA Response to DNA Damage" (2016) Giono, L.E.;Nieto Moreno, N.;Cambindo Botto, A.E. (...)Kornblihtt, A.R. Journal of Molecular Biology. 428(12):2636-2651

"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960

"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17

"Unveiling the association of STAT3 and HO-1 in prostate cancer: Role beyond heme degradation" (2012) Elguero, B.;Gueron, G.;Giudice, J. (...)Vazquez, E. Neoplasia (United States). 14(11):1043-1056

"Management of cytoskeleton architecture by molecular chaperones and immunophilins" (2011) Quintá, H.R.;Galigniana, N.M.;Erlejman, A.G. (...)Galigniana, M.D. Cellular Signalling. 23(12):1907-1920